Articles

Results 1 to 5 of 16


New Jersey Regulatory Update: Part 4

USA - September 19 2022 54 N.J.R. 449(a): Prompted by the COVID-19 pandemic, the New Jersey Board of Pharmacy ("NJ-BOP") amended regulations governing the administration of…

Labinot Alexander Berlajolli, Connor Breza, Khaled John Klele, Ryan M. Magee, William R. Meiselas

New Jersey Regulatory Update: Part 3

USA - September 14 2022 Part 3 of our New Jersey Regulatory Update continues to review regulatory changes published earlier this year through the New Jersey Register (N.J.R…

Labinot Alexander Berlajolli, Connor Breza, Khaled John Klele, Ryan M. Magee, William R. Meiselas

New Jersey Regulatory Update: Part 2

USA - September 12 2022 As we continue to focus on regulations, Part 2 of our New Jersey Regulatory Update focuses on the adoption of telemedicine rules and changes adopted…

Labinot Alexander Berlajolli, Connor Breza, Khaled John Klele, Ryan M. Magee, William R. Meiselas

Regulatory Update Part I

USA - September 6 2022 As we approach the fourth quarter of 2022, it is worth reviewing the regulatory rules that have become final in New Jersey over the approximately…

Labinot Alexander Berlajolli, Connor Breza, Khaled John Klele, Ryan M. Magee, William R. Meiselas

OIG Advisory Opinion on Specimen Collection and HIPAA Guidance

USA - August 30 2022 The Department of Health and Human Services ("HHS") Office of Inspector General ("OIG") issued Advisory Opinion Number 22-09 which reaffirmed the…

Labinot Alexander Berlajolli, Connor Breza, Khaled John Klele, Ryan M. Magee, William R. Meiselas